New & Noteworthy

Aug 24, 2018
Pharmaceutical Executive
Lisa Henderson examines the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
Aug 08, 2018
Pharmaceutical Executive
New trends report spotlights the promise and cautions for prospective life sciences dealmakers.
Aug 07, 2018
Pharmaceutical Executive
New York City is emerging as a hotspot for biotech incubators, including one startup whose CEO made the leap from big pharma to forging new discoveries in medical science. Michelle Maskaly reports.
Jul 20, 2018
New ideas and technological advances are two key methods leading to culture change in an organization. Graham Francis reports.
Jul 18, 2018
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi.
Jul 18, 2018
Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes.
Jul 13, 2018
Pharmaceutical Executive
Outlining a real-world case study in which building and operationalizing a patient- and customer-centric commercialization strategy drove a successful launch from a “standing start.”
Jul 13, 2018
Pharmaceutical Executive
The role of insurance and risk management in protecting middle-market distributors from the growing opioid multi-district litigation (MDL).
Jul 10, 2018
Pharmaceutical Executive
Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
native1_300x100
lorem ipsum